Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Metabolites and derivatives of ambrisentan

Metabolites and derivatives of ambrisentan

US Patent 8217155 · Granted Jul 10, 2012

Estimated economic value: $22,224,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Rapamycin for the treatment of lymphangioleiomyomatosis2024
Rapamycin for the treatment of lymphangioleiomyomatosis2023
Inhalable rapamycin formulation for treating age-related conditions2023
Inhalable rapamycin formulation for the treatment of pulmonary hypertension2022
Rapamycin for the treatment of lymphangioleiomyomatosis2021
Inhalable rapamycin formulation for treating age-related conditions2021
Apoptosis signal-regulating kinase inhibitors2021
Rapamycin for the treatment of lymphangioleiomyomatosis2019
Rapamycin for the treatment of lymphangioleiomyomatosis2019
Apoptosis signal-regulating kinase inhibitors2017
Apoptosis signal-regulating kinase inhibitors2015
Apoptosis signal-regulating kinase inhibitors2013